Table 4.
Disease | With Concurrent Eosinophilia (n = 81) |
Without Concurrent Eosinophilia (n = 143) |
|||
---|---|---|---|---|---|
Proportion | n | Proportion | n | p Value | |
Inflammation | 77% | 62 | 58% | 83 | 0.006 |
Eosinophilic lung disease | 21% | 17 | 6% | 8 | 0.0007 |
Parasitic disease | 9% | 7 | 5% | 7 | 0.27 |
IBD | 7% | 6 | 5% | 7 | 0.56 |
IMHA | 1% | 1 | 7% | 10 | 0.06 |
Bronchitis | 1% | 1 | 4% | 6 | 0.43 |
GI perforation | 1% | 1 | 3% | 5 | 0.42 |
Pancreatitis | 1% | 1 | 3% | 4 | 0.66 |
Pemphigus foliaceus | 2% | 2 | 2% | 3 | 1 |
Other inflammatory conditions | 32% | 26 | 23% | 33 | 0.16 |
Neoplasia | 19% | 15 | 40% | 57 | 0.001 |
Lymphoma | 6% | 5 | 13% | 18 | 0.17 |
Mast cell tumor | 5% | 4 | 12% | 17 | 0.10 |
Leukemia/MPNs | 0% | 0 | 6% | 9 | 0.03 |
Mesenchymal neoplasia | 4% | 3 | 3% | 5 | 1 |
Epithelial neoplasia | 4% | 3 | 3% | 4 | 0.71 |
Other neoplasia | 0% | 0 | 3% | 4 | 0.30 |
Other | 5% | 4 | 2% | 3 | 0.26 |